In a six-patient trial, a new gene-silencing drug reduced disease-related biomarkers, with no serious adverse events reported.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | China Sees Shift in Cancer Types as Cases Continue to Rise | 0 | 6.91 | 10-07-2026 |
| 2 | Saving China’s Vanishing Fields of Knowledge | 0 | 11.52 | 11-08-2026 |
| 3 | Shanghai Boy Defies Fatal Diagnosis to Become a Star Student | 0 | 8.55 | 03-07-2026 |
| 4 | Chinese Reality Show’s Medical Students Criticized as Incompetent | 0 | 7.96 | 26-10-2026 |
| 5 | Between Two Needles: The Chinese Garment Factory Built Around Dialysis | 0 | 7.34 | 20-07-2026 |
| 6 | China’s DeepZang AI Aims to Improve Tibetan Translation | 0 | 8.14 | 08-10-2026 |
| 7 | Investigation Uncovers China’s Underground Height Surgery Market | 0 | 7.77 | 01-07-2026 |
| 8 | Death Becomes Her: China’s New Hit Game Finds Fans in Failure | 0 | 8.96 | 29-06-2026 |
| 9 | Nytt läkemedel mot ovanlig form av ALS visar lovande resultat | 0 | 16.81 | 20-10-2026 |
| 10 | China Expands Work Injury Insurance for Gig Workers Nationwide | 0 | 9.97 | 06-07-2026 |